BackAN2 Therapeutics Overview

AN2 Therapeutics Current Cash

Latest current cash for ANTX: $53M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$53.49M
↑ 167.64% YoYΔ $33.50M vs prior year quarter

Peer average

Loading

AN2 Therapeutics Current Cash History

Loading

AN2 Therapeutics vs. peers: Current Cash Comparison

Loading

AN2 Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AN2 Therapeutics (ANTX) FAQ

AN2 Therapeutics (ANTX) currently reports a current cash of $53M as of March 2026. That compares with $20M in the prior-year period — up 167.6% year over year. Use the charts on this page to explore AN2 Therapeutics's current cash history and peer comparisons.

AN2 Therapeutics's current cash increased from $20M to $53M — a 167.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AN2 Therapeutics reported $53M in current cash as of March 2026. That compares with $20M in the prior-year period — up 167.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $53M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AN2 Therapeutics, and consider following ANTX for alerts when major investors trade the stock.